» Articles » PMID: 9859993

Control of Apoptosis and Mitotic Spindle Checkpoint by Survivin

Overview
Journal Nature
Specialty Science
Date 1998 Dec 22
PMID 9859993
Citations 563
Authors
Affiliations
Soon will be listed here.
Abstract

Progression of the cell cycle and control of apoptosis (programmed cell death) are thought to be intimately linked processes, acting to preserve homeostasis and developmental morphogenesis. Although proteins that regulate apoptosis have been implicated in restraining cell-cycle entry and controlling ploidy (chromosome number), the effector molecules at the interface between cell proliferation and cell survival have remained elusive. Here we show that a new inhibitor of apoptosis (IAP) protein, survivin, is expressed in the G2/M phase of the cell cycle in a cycle-regulated manner. At the beginning of mitosis, survivin associates with microtubules of the mitotic spindle in a specific and saturable reaction that is regulated by microtubule dynamics. Disruption of survivin-microtubule interactions results in loss of survivin's anti-apoptosis function and increased caspase-3 activity, a mechanism involved in cell death, during mitosis. These results indicate that survivin may counteract a default induction of apoptosis in G2/M phase. The overexpression of survivin in cancer may overcome this apoptotic checkpoint and favour aberrant progression of transformed cells through mitosis.

Citing Articles

Evolving Immunotherapy Strategies in Gastrointestinal Neuroendocrine Neoplasms.

Urman A, Schonman I, De Jesus-Acosta A Curr Treat Options Oncol. 2025; 26(2):92-102.

PMID: 39843688 DOI: 10.1007/s11864-024-01283-4.


Peptide-Based Turn-On Fluorescent Probes for Highly Specific Detection of Survivin Protein in the Cancer Cells.

Fuchigami T, Nakayama T, Miyanari Y, Nozaki I, Ishikawa N, Tagawa A Chem Biomed Imaging. 2024; 2(5):374-383.

PMID: 39474121 PMC: 11504145. DOI: 10.1021/cbmi.4c00017.


FOXM1 Transcriptionally Co-Upregulates Centrosome Amplification and Clustering Genes and Is a Biomarker for Poor Prognosis in Androgen Receptor-Low Triple-Negative Breast Cancer.

Rida P, Baker S, Saidykhan A, Bown I, Jinna N Cancers (Basel). 2024; 16(18).

PMID: 39335162 PMC: 11429756. DOI: 10.3390/cancers16183191.


Molecular Insights into the Anticancer Activity of Withaferin-A: The Inhibition of Survivin Signaling.

Wadhwa R, Wang J, Shefrin S, Zhang H, Sundar D, Kaul S Cancers (Basel). 2024; 16(17).

PMID: 39272948 PMC: 11394585. DOI: 10.3390/cancers16173090.


Survivin inhibition attenuates EGF-induced epithelial mesenchymal transformation of human RPE cells via the EGFR/MAPK pathway.

Zhu Y, Li T, Zhou S, Wang G, Zhang H, Yin Y PLoS One. 2024; 19(8):e0309539.

PMID: 39213375 PMC: 11364297. DOI: 10.1371/journal.pone.0309539.